Pharmacogenomics. Challenges and Opportunities in Therapeutic Implementation

Content: 
Front Matter, Page iii
Copyright, Page iv
Dedication, Page v
List of Contributors, Pages xi-xii, L. Annemans, Christina L. Aquilante, Denise Avard, Cornelis Boersma, John A. Bostrom, Daniel A. Brazeau, Gayle A. Brazeau, Jürgen Brockmöller, Lela Buckingham, Larisa H. Cavallari, Julio D. Duarte, Sisi Feng, Naoki Fukui, Shiew-Mei Huang, Lou Huei-xin, Yann Joly, Edmund Jon Deoon Lee, Emily Kirby, Teri E. Klein, Bartha M. Knoppers,  et al.
Preface, Pages xiii-xiv, Y.W. Francis Lam, Larisa H. Cavallari
Chapter 1 - Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications, Pages 1-44, Y.W. Francis Lam, Larisa H. Cavallari
Chapter 2 - Translating Pharmacogenomic Research to Therapeutic Potentials, Pages 45-61, Y.W. Francis Lam
Chapter 3 - Governmental and Academic Efforts to Advance the Field of Pharmacogenomics, Pages 63-88, Larisa H. Cavallari, Teri E. Klein, Shiew-Mei Huang
Chapter 4 - Pharmacogenomics in Cancer Therapeutics, Pages 89-116, Michael E. Schaffer, J. Suso Platero
Chapter 4A - A Look to the Future: Cancer Epigenetics, Pages 117-131, Lela Buckingham
Chapter 5 - Pharmacogenetics in Cardiovascular Diseases, Pages 133-182, Larisa H. Cavallari, Kathryn Momary
Chapter 5A - A Look to the Future: Cardiovascular Pharmacoepigenetics, Pages 183-189, Julio D. Duarte
Chapter 6 - Pharmacogenomics in Psychiatric Disorders, Pages 191-223, Y.W. Francis Lam, Naoki Fukui, Takuro Sugai, Junzo Watanabe, Yuichiro Watanabe, Yutato Suzuki, Toshiyuki Someya
Chapter 6A - A Look to the Future: Epigenetics in Psychiatric Disorders and Treatment, Pages 225-246, John A. Bostrom, Monsheel Sodhi
Chapter 7 - The Role of Pharmacogenomics in Diabetes, HIV Infection, and Pain Management, Pages 247-271, Christina L. Aquilante, Y.W. Francis Lam
Chapter 8 - Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development, Pages 273-294, Wenbo Mu, Wei Zhang
Chapter 8A - Modeling the Pharmacogenetic Architecture of Drug Response, Pages 295-308, Yafei Lu, Xin Li, Sisi Feng, Yongci Li, Xiaofeng Zeng, Mengtao Li, Xinjuan Liu, Rongling Wu
Chapter 9 - Study Designs in Clinical Pharmacogenetic and Pharmacogenomic Research, Pages 309-341, Julia Stingl (formerly Kirchheiner), Jürgen Brockmöller
Chapter 9A - Incorporating Pharmacogenomics in Drug Development: A Perspective from Industry, Pages 343-366, Ophelia Yin
Chapter 10 - The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging, Pages 367-404, Elsa Haniffah Mejia Mohamed, Lou Huei-xin, Jalene Poh, Dorothy Toh, Edmund Jon Deoon Lee
Chapter 11 - Beyond ELSIs: Where to from Here? From “Regulating” to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine, Pages 405-428, Vural Özdemir, Yann Joly, Emily Kirby, Denise Avard, Bartha M. Knoppers
Chapter 12 - Pharmacoeconomics of Pharmacogenetics within the Context of General Health Technology Assessments, Pages 429-450, Maarten J. Postma, Cornelis Boersma, S. Vegter, Dominique Vandijck, L. Annemans
Chapter 13 - Integrating Genomics into Pharmacy Education and Practice: Pharmacogenomics Is Not Enough, Pages 451-467, Daniel A. Brazeau, Gayle A. Brazeau
Color Plates, Pages 1-4
Index, Pages 469-496